Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ctDNA Monitoring”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07517107
What this trial is testing

Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 600
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07292207
What this trial is testing

Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer

Who this might be right for
ctDNA MonitoringBreast Cancer
Nagoya City University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05708235
What this trial is testing

A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population

Who this might be right for
Breast Cancer
MedSIR 976
Not applicableLooking for participantsNCT04157569
What this trial is testing

CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia

Who this might be right for
Acute Leukemia
Navy General Hospital, Beijing 200
Testing effectiveness (Phase 2)Looking for participantsNCT05868226
What this trial is testing

PRE-ISPY Phase I/II Oncology Platform Program

Who this might be right for
HER2-positive Breast CancerMetastatic CancerMetastatic Breast Cancer+29 more
QuantumLeap Healthcare Collaborative 280
Not applicableNot Yet RecruitingNCT05759325
What this trial is testing

An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Esophagus
Guangzhou Institute of Respiratory Disease 100
Not applicableUnknownNCT05649475
What this trial is testing

Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant Therapy

Who this might be right for
Stage I-III Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Not applicableUnknownNCT03737539
What this trial is testing

Dynamic Monitoring of ctDNA Methylation to Predict Relapse in Colorectal Cancer After Radical Resection (POSTCA)

Who this might be right for
Colorectal CancerCirculating Tumor DNASurveillance+1 more
Fudan University 300
Not applicableLooking for participantsNCT04976296
What this trial is testing

MRD Monitoring in Lung Cancer After Resection

Who this might be right for
Lung Cancer
Guangdong Provincial People's Hospital 300
Not applicableUnknownNCT05816642
What this trial is testing

Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
RenJi Hospital 500
Not applicableStudy completedNCT02718651
What this trial is testing

Blood-based Identification and Monitoring of Patients With ALK-translocated Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University of Aarhus 70
Not applicableLooking for participantsNCT06561178
What this trial is testing

Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-Sen University Cancer Center 50
Not applicableNot Yet RecruitingNCT06449846
What this trial is testing

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma ResectableSurgeryRecurrence
Zhujiang Hospital 152
Not applicableUnknownNCT05900583
What this trial is testing

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

Who this might be right for
Minimal Residual DiseaseEsophageal Squamous Cell Carcinoma
Guangdong Provincial People's Hospital 50
Not applicableActive Not RecruitingNCT05444491
What this trial is testing

Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer

Who this might be right for
Colorectal Cancer
Singlera Genomics Inc. 800
Testing effectiveness (Phase 2)Looking for participantsNCT06970912
What this trial is testing

CtDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast CancerHigh-risk Breast CancerEarly-Stage Breast Cancer+3 more
Peking University People's Hospital 393
Not applicableUnknownNCT03947736
What this trial is testing

Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR

Who this might be right for
Recurrent or Metastatic Breast Cancer
Chinese Academy of Medical Sciences 200
Not applicableStudy completedNCT03465241
What this trial is testing

CtDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS

Who this might be right for
NSCLC
Sun Yat-sen University 119
Not applicableLooking for participantsNCT04957901
What this trial is testing

The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study

Who this might be right for
Lymphoma
Sun Yat-sen University 60
Not applicableActive Not RecruitingNCT02842203
What this trial is testing

Use of ctDNA for Monitoring of Stage III Colorectal Cancer

Who this might be right for
Stage III Colorectal Cancer
University of Pittsburgh 137
Next Page